Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.

Tel J, Hato SV, Torensma R, Buschow SI, Figdor CG, Lesterhuis WJ, de Vries IJ.

Cancer Immunol Immunother. 2012 Jul;61(7):1101-11. doi: 10.1007/s00262-011-1189-x. Epub 2011 Dec 23.

2.

EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape.

Severa M, Giacomini E, Gafa V, Anastasiadou E, Rizzo F, Corazzari M, Romagnoli A, Trivedi P, Fimia GM, Coccia EM.

Eur J Immunol. 2013 Jan;43(1):147-58. doi: 10.1002/eji.201242552. Epub 2012 Oct 30.

3.

Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells.

Song S, Yuan P, Wu H, Chen J, Fu J, Li P, Lu J, Wei W.

Int Immunopharmacol. 2014 May;20(1):117-23. doi: 10.1016/j.intimp.2014.02.027. Epub 2014 Mar 4.

PMID:
24606770
4.

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.

J Immunol. 2003 Oct 15;171(8):4320-8.

5.

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.

Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M.

Cancer Res. 2015 Dec 1;75(23):5034-45. doi: 10.1158/0008-5472.CAN-14-3098. Epub 2015 Nov 16.

6.

Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells.

Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP, Söderberg-Nauclér C.

J Immunol. 2007 Dec 1;179(11):7767-76.

7.
8.

Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand.

Yrlid U, Milling SW, Miller JL, Cartland S, Jenkins CD, MacPherson GG.

J Immunol. 2006 May 1;176(9):5205-12.

9.

Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.

Schroeder JT, Chichester KL, Bieneman AP.

J Allergy Clin Immunol. 2008 Feb;121(2):486-91. Epub 2007 Nov 26.

PMID:
18036648
10.

The STATus of PD-L1 (B7-H1) on tolerogenic APCs.

Sumpter TL, Thomson AW.

Eur J Immunol. 2011 Feb;41(2):286-90. doi: 10.1002/eji.201041353.

11.

Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.

Encabo A, Solves P, Mateu E, Sepúlveda P, Carbonell-Uberos F, Miñana MD.

Stem Cells. 2004;22(5):725-40.

12.

Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response.

Srivastava RM, Varalakshmi Ch, Khar A.

Int Immunol. 2007 May;19(5):591-607. Epub 2007 Mar 15.

PMID:
17369187
13.

Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

Dental C, Florentin J, Aouar B, Gondois-Rey F, Durantel D, Baumert TF, Nunes JA, Olive D, Hirsch I, Stranska R.

J Virol. 2012 Jan;86(2):1090-6. doi: 10.1128/JVI.05444-11. Epub 2011 Nov 16.

14.

Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.

Douagi I, Gujer C, Sundling C, Adams WC, Smed-Sörensen A, Seder RA, Karlsson Hedestam GB, Loré K.

J Immunol. 2009 Feb 15;182(4):1991-2001. doi: 10.4049/jimmunol.0802257.

15.

Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.

Ngan CY, Yamamoto H, Takagi A, Fujie Y, Takemasa I, Ikeda M, Takahashi-Yanaga F, Sasaguri T, Sekimoto M, Matsuura N, Monden M.

Cancer Sci. 2008 Jan;99(1):129-39. Epub 2007 Oct 19.

16.

Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.

Li W, Wang X, Chen R, Zhu H, Chen G, Sun X.

J Surg Res. 2012 Aug;176(2):e79-87. doi: 10.1016/j.jss.2011.12.009. Epub 2011 Dec 30.

PMID:
22381170
17.
18.

A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.

Haidinger M, Poglitsch M, Geyeregger R, Kasturi S, Zeyda M, Zlabinger GJ, Pulendran B, Hörl WH, Säemann MD, Weichhart T.

J Immunol. 2010 Oct 1;185(7):3919-31. doi: 10.4049/jimmunol.1000296. Epub 2010 Aug 30.

19.

A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.

Ju S, Ju S, Ge Y, Qiu H, Lu B, Qiu Y, Fu J, Liu G, Wang Q, Hu Y, Shu Y, Zhang X.

Int Immunol. 2009 Oct;21(10):1135-44. doi: 10.1093/intimm/dxp077. Epub 2009 Aug 14.

PMID:
19684160
20.

DC-SIGN ligation greatly affects dendritic cell differentiation from monocytes compromising their normal function.

Svajger U, Obermajer N, Anderluh M, Kos J, Jeras M.

J Leukoc Biol. 2011 Jun;89(6):893-905. doi: 10.1189/jlb.0810463. Epub 2011 Mar 29.

PMID:
21447648

Supplemental Content

Support Center